Provided by Tiger Fintech (Singapore) Pte. Ltd.

C4 Therapeutics, Inc.

1.40
+0.150012.00%
Post-market: 1.450.0500+3.57%18:20 EDT
Volume:1.50M
Turnover:2.10M
Market Cap:99.39M
PE:-0.92
High:1.49
Open:1.24
Low:1.20
Close:1.25
Loading ...

C4 Therapeutics: Cash Runway Expected to Fund Operations Into 2027

THOMSON REUTERS
·
14 Jan

C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology

GlobeNewswire
·
14 Jan

Greentown China Expands Project Services with CCCC Southeast Engineering

TIPRANKS
·
10 Jan

C4 Therapeutics price target raised to $50 from $39 at Brookline

TIPRANKS
·
06 Jan

Here's Why C4 Therapeutics (CCCC) Is a Great 'Buy the Bottom' Stock Now

Zacks
·
02 Jan

Greentown China Holdings' Unit Partners Sanya Huangzhuo for Provision of Project Management Services

MT Newswires Live
·
02 Jan

Why C4 Therapeutics (CCCC) Is One of the Best Biotech Penny Stocks to Invest in Now?

Insider Monkey
·
31 Dec 2024

Wells Fargo Upgrades C4 Therapeutics to Overweight From Equalweight, Raises Price Target to $12 From $8

MT Newswires Live
·
19 Dec 2024

C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo

TIPRANKS
·
19 Dec 2024

CCCG Real Estate Completes Acquisition of CCCC Property Services; Shares Drop 4%

MT Newswires Live
·
13 Dec 2024

Analysts Offer Insights on Healthcare Companies: Geron (GERN), Merus (MRUS) and C4 Therapeutics (CCCC)

TIPRANKS
·
09 Dec 2024

C4 Therapeutics (CCCC) Gets a Hold from Morgan Stanley

TIPRANKS
·
09 Dec 2024

C4 Therapeutics presents cemsidomide Phase 1 data at ASH

TIPRANKS
·
09 Dec 2024

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader

GlobeNewswire
·
09 Dec 2024

BRIEF-C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter To Board Of Directors

Reuters
·
20 Nov 2024

C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

THOMSON REUTERS
·
20 Nov 2024

Press Release: C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

Dow Jones
·
20 Nov 2024

U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix

Reuters
·
19 Nov 2024

C4 Therapeutics initiated with an Equal Weight at Stephens

TIPRANKS
·
18 Nov 2024

BRIEF-C4 Therapeutics Inc Files For Stock Shelf Offering Of Up To $200 Million - SEC Filing

Reuters
·
16 Nov 2024